Ankylosing spondylitis natural history, complications and prognosis

Jump to: navigation, search

Ankylosing spondylitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ankylosing spondylitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ankylosing spondylitis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ankylosing spondylitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ankylosing spondylitis natural history, complications and prognosis

CDC on Ankylosing spondylitis natural history, complications and prognosis

Ankylosing spondylitis natural history, complications and prognosis in the news

Blogs on Ankylosing spondylitis natural history, complications and prognosis

Directions to Hospitals Treating Ankylosing spondylitis

Risk calculators and risk factors for Ankylosing spondylitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

The natural history of ankylosing spondylitis(AS) remains poorly documented.Documentation of the early course of ankylosing spondylitis(AS) has been limited by the lack of appropriate criteria to diagnose early.New York criteria had played important role in the study of ankylosing spondylitis(AS).

Natural History, Complications, and Prognosis

Natural History[1][2][3]

Complications

Prognosis

  • It's hard to predict the long-term effects for the people who are suffering with ankylosing spondylitis because it varies from person to person.
  • The presence of hip involvement is associated with a particularly poor prognosis among patients with ankylosing spondylitis patients.[11]
  • In many patients onset of the disease and symptoms varies.
  • In a very small percentage of the patients with AS they develop life-threatening complications like abnormal heart rhythm or the aortic heart valve.

References

  1. Goie The HS, Steven MM, van der Linden SM, Cats A (August 1985). "Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis". Br. J. Rheumatol. 24 (3): 242–9. PMID 3160423. 
  2. Robertson LP, Davis MJ (December 2004). "A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis". Rheumatology (Oxford). 43 (12): 1565–8. PMID 15353608. doi:10.1093/rheumatology/keh386. 
  3. van der Linden S, Valkenburg HA, Cats A (April 1984). "Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria". Arthritis Rheum. 27 (4): 361–8. PMID 6231933. 
  4. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans B, Dougados M, Emery P, van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlam K, Sieper J (June 2009). "The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal". Ann. Rheum. Dis. 68 (6): 770–6. PMID 19297345. doi:10.1136/ard.2009.108217. 
  5. van den Berg R, van der Heijde DM (November 2010). "How should we diagnose spondyloarthritis according to the ASAS classification criteria: a guide for practicing physicians". Pol. Arch. Med. Wewn. 120 (11): 452–7. PMID 21102381. 
  6. Stolwijk C, Essers I, van Tubergen A, Boonen A, Bazelier MT, De Bruin ML, de Vries F (July 2015). "The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study". Ann. Rheum. Dis. 74 (7): 1373–8. PMID 24658834. doi:10.1136/annrheumdis-2014-205253. 
  7. Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A (January 2015). "Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis". Ann. Rheum. Dis. 74 (1): 65–73. PMID 23999006. doi:10.1136/annrheumdis-2013-203582. 
  8. Stolwijk C, Essers I, van Tubergen A, Boonen A, Bazelier MT, De Bruin ML, de Vries F (July 2015). "The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study". Ann. Rheum. Dis. 74 (7): 1373–8. PMID 24658834. doi:10.1136/annrheumdis-2014-205253. 
  9. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL (September 2016). "Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis". Arthritis Res. Ther. 18: 196. PMC 5009714Freely accessible. PMID 27586785. doi:10.1186/s13075-016-1093-z. 
  10. Li Y, Zhang S, Zhu J, Du X, Huang F (October 2012). "Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study". Arthritis Res. Ther. 14 (5): R215. PMC 3580527Freely accessible. PMID 23058191. doi:10.1186/ar4054. 
  11. Vander Cruyssen B, Muñoz-Gomariz E, Font P, Mulero J, de Vlam K, Boonen A, Vazquez-Mellado J, Flores D, Vastesaeger N, Collantes E (January 2010). "Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery". Rheumatology (Oxford). 49 (1): 73–81. PMID 19605374. doi:10.1093/rheumatology/kep174. 

Linked-in.jpg